000
| 01100nas 2200265za 4500 |
---|
001 | 9.856497 |
---|
003 | CaOODSP |
---|
005 | 20221107155538 |
---|
007 | cr ||||||||||| |
---|
008 | 180511d20152021oncar p o |||f0 a0eng|d |
---|
022 | |a2561-7613 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aH166-2E-PDF |
---|
110 | 1 |aCanada. |bTherapeutic Products Directorate. |
---|
222 | 0|aDrug submission performance annual report ... |b(Canada. Therapeutic Products Directorate) |
---|
245 | 10|aDrug submission performance annual report ... |h[electronic resource] / |cTherapeutic Products Directorate. |
---|
246 | 37|aTPD annual drug submission performance report |
---|
260 | |aOttawa : |bHealth Canada, |c[2015]-2021. |
---|
310 | |aAnnual |
---|
362 | 1 |aBegan with 2014/2015; ceased with 2020-2021. |
---|
500 | |aIssued also in French under title: Rapport annuel du rendement des présentations de drogue. |
---|
710 | 1 |aCanada. |bHealth Canada. |
---|
775 | 08|tRapport annuel du rendement des présentations de drogue ... |w(CaOODSP)9.856501 |
---|
785 | 00|tDrug submission performance annual report.|w(CaOODSP)9.912627 |
---|